BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Prognosis
13 results:

  • 1. Simultaneous nbs1 and p53 inactivation in neural progenitors triggers high-grade gliomas.
    Reuss DE; Downing SM; Camacho CV; Wang YD; Piro RM; Herold-Mende C; Wang ZQ; Hofmann TG; Sahm F; von Deimling A; McKinnon PJ; Frappart PO
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12915. PubMed ID: 37296499
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. RNF126-Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple-Negative Breast cancer to Radiotherapy.
    Liu W; Zheng M; Zhang R; Jiang Q; Du G; Wu Y; Yang C; Li F; Li W; Wang L; Wu J; Shi L; Li W; Zhang K; Zhou Z; Liu R; Gao Y; Huang X; Fan S; Zhi X; Jiang D; Chen C
    Adv Sci (Weinh); 2023 Feb; 10(5):e2203884. PubMed ID: 36563124
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
    Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
    Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor prognosis of Glioblastoma.
    Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D
    Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Advances in the Surgical Treatment of Neuroblastoma.
    Luo YB; Cui XC; Yang L; Zhang D; Wang JX
    Chin Med J (Engl); 2018 Oct; 131(19):2332-2337. PubMed ID: 30246719
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma.
    Gholamin S; Mirzaei H; Razavi SM; Hassanian SM; Saadatpour L; Masoudifar A; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):866-879. PubMed ID: 28145567
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells.
    Park JH; Szemes M; Vieira GC; Melegh Z; Malik S; Heesom KJ; Von Wallwitz-Freitas L; Greenhough A; Brown KW; Zheng YG; Catchpoole D; Deery MJ; Malik K
    Mol Oncol; 2015 Mar; 9(3):617-27. PubMed ID: 25475372
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.
    Perry C; Agarwal D; Abdel-Fatah TM; Lourdusamy A; Grundy R; Auer DT; Walker D; Lakhani R; Scott IS; Chan S; Ball G; Madhusudan S
    Oncotarget; 2014 Jul; 5(14):5764-81. PubMed ID: 25026297
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of novel candidate compounds targeting TrkB to induce apoptosis in neuroblastoma.
    Nakamura Y; Suganami A; Fukuda M; Hasan MK; Yokochi T; Takatori A; Satoh S; Hoshino T; Tamura Y; Nakagawara A
    Cancer Med; 2014 Feb; 3(1):25-35. PubMed ID: 24403123
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Regulation of MYCN expression in human neuroblastoma cells.
    Jacobs JF; van Bokhoven H; van Leeuwen FN; Hulsbergen-van de Kaa CA; de Vries IJ; Adema GJ; Hoogerbrugge PM; de Brouwer AP
    BMC Cancer; 2009 Jul; 9():239. PubMed ID: 19615087
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Useful markers for detecting minimal residual disease in cases of neuroblastoma.
    Ootsuka S; Asami S; Sasaki T; Yoshida Y; Nemoto N; Shichino H; Chin M; Mugishima H; Suzuki T
    Biol Pharm Bull; 2008 Jun; 31(6):1071-4. PubMed ID: 18520032
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analyses of novel prognostic factors in neuroblastoma patients.
    Ootsuka S; Asami S; Sasaki T; Yoshida Y; Nemoto N; Shichino H; Chin M; Mugishima H; Suzuki T
    Biol Pharm Bull; 2007 Dec; 30(12):2294-9. PubMed ID: 18057715
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. 3,4-dihydroxyphenylalanine (DOPA) decarboxylase deficiency and resultant high levels of plasma DOPA and dopamine in unfavorable neuroblastoma.
    Ikeda H; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M
    Hypertens Res; 1995 Jun; 18 Suppl 1():S209-10. PubMed ID: 8529065
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.